Domperidone remains unapproved by the FDA for use in the United States. This means it’s not legally available through typical pharmaceutical channels. Importation for personal use is also generally prohibited without a specific FDA exemption, often difficult to obtain.
Challenges to FDA Approval
The FDA’s primary concern revolves around potential cardiac side effects, specifically QT prolongation, requiring rigorous clinical trials to establish a safe and effective dosage regimen for specific indications. The extensive data needed to satisfy FDA requirements presents a significant hurdle for manufacturers.
Potential Pathways to Availability
Several avenues could potentially lead to future domperidone availability. A pharmaceutical company could initiate a new drug application (NDA) providing the necessary clinical data to satisfy FDA safety and efficacy standards. Alternatively, a successful petition for expanded access or compassionate use might provide limited access in exceptional cases under strict medical supervision. However, the likelihood and timeline for either scenario remain uncertain.
Recommendations
Patients seeking domperidone should consult their physicians. Exploring alternative FDA-approved medications for similar conditions represents the safest and most responsible approach. Discuss potential risks and benefits with your doctor before considering any unapproved treatments, including those obtained through unofficial channels.
